Forty years of practice against gastric cancer in Linqu County, a high-risk area of gastric cancer in China

Abstract

Gastric cancer (GC) is a global public health burden, with nearly one million new cases diagnosed each year worldwide. To investigate the risk factors and the prevention strategies for GC, in the past 40 years, a series of epidemiological studies have been carried out in Linqu County, Shandong Province, a high-risk area of GC in China. Here, we briefly review the major efforts of 40-year practices against GC in Linqu County, particularly highlighting a case-control study to identify GC risk factors, a cohort study to determine the associations between the risk factors and the progression of gastric lesions, and an intervention trial to prevent GC development.

Keywords

gastric cancer / precancerous gastric lesions / Helicobacter pylori / risk factor / prevention

References

[1] Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Center. 2024;4:47-53.

[2] Wang TG, You WC, Henderson BE, Blot WJ. A case-control study of stomach cancer in Shandong province. Natl Cancer Inst Monogr. 1985;69:9-10.

[3] International Agency for Research on Cancer of World Health Organization. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. IARC working group reports. International Agency for Research on Cancer of World Health Organization website. 2014.

[4] You WC, Blot WJ, Chang YS, et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 1988;48(12):3518-3523.

[5] Zhang L, Blot WJ, You WC, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomark Prev. 1996;5(8):627-630.

[6] You W, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000;92(19):1607-1612.

[7] Wong BCY, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291(2):187-194.

[8] Ma JL, You WC, Gail MH, et al. Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer. Int J Epidemiol. 1998;27(4):570-573.

[9] Zhang L, Ma J, Pan K, et al. [Studies on infection of Helicobacter pylori and their subtypes cagA+ and hspA+ in population living in the areas with high and low incidence of gastric cancer]. Zhonghua yu fang yi xue za zhi [Chinese J Prevent Med]. 1998;32(2):67-69.

[10] You WC, Zhang L, Pan KF, et al. Helicobacter pylori prevalence and CagA status among children in two counties of China with high and low risks of gastric cancer. Ann Epidemiol. 2001;11(8):543-546.

[11] Lam TK, Freedman ND, Fan JH, et al. Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population. Am J Clin Nutr. 2013;98(5):1289-1297.

[12] Gonzalez CA, Riboli E. Diet and cancer prevention: contributions from the European prospective investigation into cancer and nutrition (EPIC) study. Eur J Cancer. 2010;46(14):2555-2562.

[13] You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res. 1993;53(6):1317-1321.

[14] You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high-risk of gastric cancer. Int J Cancer. 1999;83(5):615-619.

[15] You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98(14):974-983.

[16] Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488-492.

[17] Li WQ, Ma JL, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014;106(7):dju116.

[18] Herrero R, Parsonnet J, Greenberg ER. Prevention of gastric cancer. JAMA. 2014;312:1197-1198.

[19] Li WQ, Zhang JY, Ma JL, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019;366:l5016.

[20] Guo Y, Li ZX, Zhang JY, et al. Association between lifestyle factors, vitamin and garlic supplementation, and gastric cancer outcomes: a secondary analysis of a clinical trial. JAMA Netw Open. 2020;3(6):e206628.

[21] Malfertheiner P, Sipponen P, Naumann M, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol. 2005;100(9):2100-2115.

[22] National Clinical Research Center for Digestive Diseases (Shanghai) NEGCPaTCAG, Helicobacter pylori Committee of Chinese Society of Gastroenterology, Gastric Cancer Committee of Chinese Society of Surgery, Chinese Health Management Association, Digestive Endoscopy Committee of Chinese Endoscopist Association of Chinese Medical Doctor Association, Digestive Endoscopy Health Management & Physical Examination Committee of Chinese Endoscopist Association of Chinese Medical Doctor Association, Tumor Endoscopy Committee of China Anti-Cancer Association. Chinese consensus on eradication of Helicobacter pylori and prevention & control of gastric cancer (2019, Shanghai). Chin J Dig. 2019;39:310-316.

[23] ChinaCDC. Chinese Consensus on “Prevention and Control of Helicobacter pylori Infection in China”. ChinaCDC. 2023.

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Malignancy Spectrum published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.